Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report.

Haiyue NiuWeiwei QiYihao WangLimin XingRong FuZonghong ShaoHuaquan Wang

Published in: Medicine (2020)

We consider that sirolimus is a safe, effective, and well-tolerated oral drug that can be used as a treatment for aplastic anemia patients with chronic kidney disease.

Keyphrases

chronic kidney disease
end stage renal disease
allogeneic hematopoietic stem cell transplantation
iron deficiency
case report
stem cells
emergency department
acute lymphoblastic leukemia
combination therapy
acute myeloid leukemia
replacement therapy
mesenchymal stem cells